225 results
8-K
EX-99.1
ALIM
Alimera Sciences Inc.
7 Mar 24
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results
8:32am
7, 2024.
Conference Call replay: US Toll Free: 1-877-344-7529
International Toll: 1-412-317-0088
Canada Toll Free: 855-669-9658
Replay Access Code
8-K
EX-10.2
ALIM
Alimera Sciences Inc.
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
and whether or not Executive is authorized to have access to such information) during the term of Executive’s employment by the Company or any of its … or not developed or compiled by Executive and whether or not Executive is authorized to have access to such information) during the term
8-K
EX-10.1
ALIM
Alimera Sciences Inc.
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
or not developed or compiled by Executive and whether or not Executive was authorized to have access to such information) during the term of Executive’s employment … or compiled by Executive and whether or not Executive was authorized to have access to such information) during the term of and in the course
8-K
EX-99.1
1mygc3u 4gql5bfa2iyt
12 Dec 23
Departure of Directors or Certain Officers
5:09pm
8-K
EX-10.2
9vxohvbu0yq 2yxknj
12 Dec 23
Departure of Directors or Certain Officers
5:09pm
8-K
EX-10.1
mziz ky4rcbcx
12 Dec 23
Departure of Directors or Certain Officers
5:09pm
8-K
EX-99.1
vcmig ehzjsmz38rc
26 Oct 23
Alimera Sciences Reports Third Quarter 2023 Results
7:39am
8-K
EX-10.1
ij8k3xln
3 Oct 23
Alimera Sciences Appoints Jason Werner as Chief Operating Officer
7:00am
8-K
EX-10.2
gg411kczc32op
2 Aug 23
Unregistered Sales of Equity Securities
5:18pm
8-K
EX-10.1
pdiu121j9
2 Aug 23
Unregistered Sales of Equity Securities
5:18pm
8-K
EX-99.1
d0kjbvuq22hk vu6
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
8-K
EX-2.1
xdjkjlx0 6f63z
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm